« Back
Home /
Maropitant

Maropitant

Item no.	M1832-1g
Manufacturer	AbMole
CASRN	147116-67-4
Amount	1g
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Uterine, Ovarian & Cervical Cancer
Type	Inhibitors
Specific against	other
Purity	>99.0%
Citations	Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs. Boscan, et al . Am J Vet Res. 2011 Dec,72(12):1576-9. PMID: 22126683 . Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs. Alvillar, et al . Vet Anaesth Analg. 2012 Mar,39(2):201-5. PMID: 22103569 . The use of maropitant to prevent vomiting induced by epidural administration of preservative free morphine through an epidural catheter in a dog. Mathis, et al . Vet Anaesth Analg. 2011 Sep,38(5):516-7. PMID: 21831059 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Similar products	Maropitant
Available
Target Information	Neurokinin Receptor
Molecular Weight	468, 67
Solubility	DMSO 10 mM
Bioactivity information	Maropitant (Cerenia) is a novel, selective neurokinin type-1 (NK1) receptor antagonist.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1832-1g-safety-datasheet.pdf